The company that created the first genome sequencing test for IVF embryo screening has partnered with the world’s leading polygenic embryo testing company to launch the most significant advance in IVF genetics in a generation. Together, they are making clinical-grade embryo-genome sequencing available at a price that changes everything. SHANGHAI, April 30, 2026 (GLOBE NEWSWIRE) — GenEmbryomics Limited (Sydney, Australia) and Genomic Prediction, Inc. (New Jersey, USA) today announced the launch of XGEN PGT-X™ at the 23rd International Conference on Preimplantation Genetics (PGDIS 2026) in Shanghai, China — the world’s first clinical-grade embryo-genome sequencing test available at less than US$500…